Skip to main content
TALPHERA, INC. logo

TALPHERA, INC. — Investor Relations & Filings

Ticker · TLPH ISIN · US00444T2096 LEI · 549300U8W781S4RBUE66 US Manufacturing
Open in API
Filings indexed 840 across all filing types
Latest filing 2026-05-13 Interim / Quarterly Rep…
Country US United States of America
Listing US TLPH

About TALPHERA, INC.

https://talphera.com/

Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies designed for use in medically supervised settings. The company aims to support healthcare providers and optimize patient outcomes. A key product in its development pipeline is Niyad, a lyophilized formulation of nafamostat. The company was formerly known as AcelRx Pharmaceuticals Inc.

Recent filings

Filing Released Lang Actions
10-Q - TALPHERA, INC. (0001427925) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-13 English
DEF 14A - TALPHERA, INC. (0001427925) (Filer)
Proxy Solicitation & Information Statement
2026-04-29 English
4 - TALPHERA, INC. (0001427925) (Issuer)
Director's Dealing
2026-03-26 English
8-K - TALPHERA, INC. (0001427925) (Filer)
Earnings Release Classification · 90% confidence The document is a Form 8-K filed with the SEC, dated March 23, 2026, for Talphera, Inc. It announces the issuance of a press release containing financial results for the three and twelve months ended December 31, 2025, and a corporate update. The document explicitly states that the information is "furnished" and not "filed," and it includes a press release as Exhibit 99.1. The length of the document is 3727 characters, which is relatively short and primarily serves as an announcement of the earnings release rather than containing the financial results themselves. According to the rules, such a document is best classified as an Earnings Release (ER) since it announces quarterly/periodical financial results highlights. However, since the document itself does not contain the full financial data but only announces the press release, it fits the definition of an Earnings Release announcement. Given the short length and nature, the confidence is high but not absolute because the actual detailed financials are in the press release exhibit, not the 8-K text itself.
2026-03-23 English
4 - TALPHERA, INC. (0001427925) (Issuer)
Director's Dealing
2026-03-17 English
4 - TALPHERA, INC. (0001427925) (Issuer)
Director's Dealing
2026-02-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.